Amneal Pharmaceuticals (AMRX) Q1 Earnings Beat Estimates

Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of$ 0.15 per share. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 40%. A quarter ago, it was expected that this pharmaceutical company would post earnings of$ 0.15 per share when it actually produced earnings of $0.12, delivering a surprise of -20%.Over the last four quart ...